News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diabetes Drugs May Lower Risk of Lung Cancer, University of Arkansas for Medical Sciences Study Finds



5/4/2007 2:35:29 AM

NEW YORK (Reuters Health) - The use of diabetes drugs called thiazolidinediones, such as rosiglitazone (Avandia) and pioglitazone (Actos), may reduce the risk of lung cancer, according to a report in the Journal of Clinical Oncology. These are preliminary findings, Dr. Rangaswamy Govindarajan from the University of Arkansas for Medical Sciences, Little Rock, told Reuters Health. "Physicians should be cautioned not to start using these agents for cancer prevention."

>>> Discuss This Story


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES